For many years, drug development has relied on simplified and scalable cell culture models to find and test new drugs for a wide variety of diseases. However, cells grown in a dish are often a feint representation of healthy and diseased cell types in vivo. This limitation has serious consequences: Many potential medicines that originally appear promising in cell cultures often fail to work when tested in patients, and targets may be completely missed if they do not appear in a dish.